Intraosseous infusion (IO) is the process of injecting directly into the marrow of a bone. This provides a non-collapsible entry point into the systemic venous system. This technique is used to provide fluids and medication when intravenous access is not available or not feasible. Intraosseous infusions allow for the administered medications and fluids to go directly into the vascular system.
The automatic intraosseous devices allow quick and safe access to the patient's vascular system for fluid and drug administration. There are several FDA approved IO devices: The BIG Bone Injection Gun and The NIO New Intra Osseous device are automatic intra-osseous infusion device used by military and civilian healthcare systems.

The global Intraosseous Infusion Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Intraosseous Infusion Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Intraosseous Infusion Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Intraosseous Infusion Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Intraosseous Infusion Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
BD
Cook Medical
Pyng Medical
PerSys Medical
Teleflex
PAVmed
Biopsybell
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Manual intraosseous infusion devices
Automatic intraosseous infusion devices

Segment by Application
Pre-hospital emergency care
Hospitals
Military care